Search

everythinglearnresearchcommunity

for

Search:↓

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The formulated gel is a promising treatment for alopecia areata.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Tofacitinib is effective and safe for treating alopecia areata.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.